Screen for signs of colon cancer from the
comfort of your home
What is OC-Auto FIT?
OC-Auto FIT is an at-home, noninvasive screening solution that looks for non-visible blood in the stool. OC-Auto FIT has been demonstrated as an effective part of colorectal cancer screening programs.1 For individuals over the age of 45 at average risk*, regular screening may help find signs of the disease before symptoms appear, allowing patients to get treatment early, and when survival rates are higher.
What are the benefits of OC-Auto FIT?
Easy at-home test
No preparation, restrictions, or special diet required
No changes to medication required
Checked annually, similar to breast and prostate cancer screening
OC-Auto FIT: Effective, early detection
Every year, millions of patients and healthcare providers around the world rely on OC-Auto FIT for annual screening.2
Not every FIT is OC-Auto FIT
OC-Auto FIT demonstrates proven performance
94.9% Specificity
High specificity for colorectal cancer means OC-Auto FIT returns fewer false positive results3†
†A positive result in the absence of disease.
Up to
84% Sensitivity
High sensitivity for colorectal cancer means OC-Auto FIT is highly effective3
Getting OC-Auto FIT is easy.
If you are between the ages of 45 and 75 and are of average risk*, be sure to ask your healthcare provider about annual screening with OC-Auto FIT, or order a kit for yourself today.
*Professional guidelines recommend regular colon cancer screening for all average-risk adults between 45-75 years of age.4-6 For screening purposes, you are at average risk of colorectal cancer if you do not have a personal history of colorectal cancer or certain types of polyps; a family history of colorectal cancer; a confirmed or suspected hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or Lynch syndrome (hereditary nonpolyposis colon cancer or HNPCC); a personal history of inflammatory bowel disease (ulcerative colitis or Crohn’s disease); or a personal history of abdominal or pelvic radiation for a previous cancer. Talk to your healthcare provider if you are not sure if you are at average or increased risk of colorectal cancer.7
OC-Auto Sensor io iFOB Test is designed to be used together as an immunoassay test system. The test system is intended for the qualitative detection of fecal occult blood in feces by professional laboratories. The automated test is used for the measurement of fecal occult blood and is useful as an aid to detect blood in stool when lower gastrointestinal bleeding may be suspected.
References:
- Levin TR, Corley DA, Jensen CD, et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155(5):1383-1391.e5. doi.org/10.1053/j.gastro.2018.07.0171.
- Data on file with Polymedco, Inc.
- Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297. doi/full/10.1056/NEJMoa1311194
- US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238
- Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458-479. doi:10.14309/ajg.0000000000001122
- Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016-1030. doi:10.1038/ajg.2017.174
- Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guidelines update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281. doi:10.3322/caac.21457
